HUTCHMED (China) (HMDCF) Property, Plant & Equipment (Net) (2015 - 2026)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.05 Bn | 197.06 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 181.07 Bn | 177.90 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.15 Bn | 124.30 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.74 Bn | 56.55 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.51 Bn | 49.37 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.88 Bn | 29.88 Bn | 1.16 Mn | 11.32 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | 93.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.79 Mn |
| Dec 31, 2025 | 94.62 Mn |
| Jun 30, 2025 | 94.57 Mn |
| Dec 31, 2024 | 92.50 Mn |
| Jun 30, 2024 | 94.82 Mn |
| Dec 31, 2023 | 99.73 Mn |
| Jun 30, 2023 | 96.83 Mn |
| Dec 31, 2022 | 75.95 Mn |
| Jun 30, 2022 | 44.06 Mn |
| Dec 31, 2021 | 41.28 Mn |
| Jun 30, 2021 | 29.17 Mn |
| Dec 31, 2020 | 24.17 Mn |
| Jun 30, 2020 | 20.84 Mn |
| Dec 31, 2019 | 20.86 Mn |
| Sep 30, 2019 | 18.53 Mn |
| Jun 30, 2019 | 17.67 Mn |
| Mar 31, 2019 | 17.04 Mn |
| Dec 31, 2018 | 16.62 Mn |
| Jun 30, 2018 | 14.42 Mn |
| Dec 31, 2017 | 14.22 Mn |